Demographic data of the study subjects.

Figshare2015-12-02 更新2026-04-29 收录

肝病临床研究

终末期肝病评分

数据链接：

https://figshare.com/articles/dataset/_Demographic_data_of_the_study_subjects_/420348 数据链接链接失效反馈

官方服务：

资源简介：

Abbreviations: MARS, Molecular adsorbent recycling system; MELD, Model for end-stage liver disease score.

创建时间：

2015-12-02

Supplementary Material for: Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort

丙型肝炎长期预后

终末期肝病评分

Background: Direct-acting antivirals (DAA) have revolutionized hepatitis C treatment, with high sustained virological response (SVR) rates reported, even in historically difficult-to-treat groups. SVR

NIAID Data Ecosystem70

Differences in baseline characteristics according to cirrhosis.

肝病临床研究

患者基线特征

Differences in baseline characteristics according to cirrhosis.

Figshare2020-08-21 更新40

Prevalence of occult hepatitis B infection in liver biopsy sample of patients with nonviral liver disease: Supplementary Figure and Table

隐匿性乙型肝炎

肝病临床研究

Aim: To determine the prevalence of occult hepatitis B (HBV) infection (OBI) in patients with nonviral liver disease. Materials & methods: This study included 83 HBsAg-negative patients followed u

DataCite Commons2024-05-17 更新40

Results of laboratory tests in four patients with HBV-associated acute liver failure.

肝病临床研究

急性肝衰竭监测

To convert the values for creatinine to µmol/L, multiply by 88.4; to convert the values for total and conjugated bilirubin to µmol/L, multiply by 17.1. †Normal range, 0.80 to 1.20 international normal

NIAID Data Ecosystem50

Cox proportional hazard model for survival prediction of non-cancer end-stage liver disease.

终末期肝病评分

临床预后模型

Cox proportional hazard model for survival prediction of non-cancer end-stage liver disease.

NIAID Data Ecosystem40